AI Science Tracker
EN

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease.

Affiliation not stated in the reviewed material · 31 Oct 2023 · medicine

Discovery

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease.

Source check: Source checked. Not independent scientific confirmation.

Finding: XGBoost applied to minute-level bedside vital-sign streams predicted acute kidney injury up to 12 hours before onset in hospitalized sickle-cell patients. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.

Technology: The classifier uses five minute-sampled physiologic streams from bedside monitors.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The classifier uses five minute-sampled physiologic streams from bedside monitors.
Test and result
In 1,178 filtered encounters across five hospitals, AUROC was 0.91 at 12 hours and 0.82 at 48 hours before AKI.
Limitation / still unknown
Retrospective regional-network evaluation with limited AKI cases; abstract and full paper note generalizability limits and no intervention outcome.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://karger.com/ajn/article-pdf/55/1/18/4163536/000534864.pdf · https://karger.com/ajn/article-pdf/55/1/18/4163536/000534864.pdf#methods · https://karger.com/ajn/article-pdf/55/1/18/4163536/000534864.pdf#results

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.